Drug:
Reaction: DRY SKIN
20250101 - 20251231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 25034566 |
US |
56 | 2 |
Dry skin, |
||||
LENALIDOMIDE, |
||||
| 602 | 25034599 |
US |
||
Bone disorder, Dry skin, Pruritus, Papule, Postmenopause, Skin exfoliation, Product quality issue, |
||||
LETROZOLE, LETROZOLE TABLETS, |
||||
| 603 | 25035100 |
US |
||
Cataract, Nausea, Diarrhoea, Dry skin, Dehydration, |
||||
OSIMERTINIB, |
||||
| 604 | 25035660 |
CA |
2 | |
Abdominal pain, Asthenia, Blister, Blood creatine phosphokinase increased, Blood iron decreased, Blood magnesium decreased, Blood pressure decreased, Blood pressure decreased, Blood pressure diastolic decreased, Blood pressure systolic decreased, Blood pressure systolic decreased, Blood pressure systolic decreased, Blood test abnormal, Breast disorder, Constipation, Constipation, Dry mouth, Dry skin, Dry throat, Dysmenorrhoea, Eczema, Electric shock sensation, Epistaxis, Epistaxis, Faeces soft, Fatigue, Fatigue, Fatigue, Gingival pain, Headache, Headache, Headache, Heart rate decreased, Hepatitis, Hyperaesthesia, Hyperaesthesia, Hyperaesthesia, Hypotension, Hypotension, Injection site haemorrhage, Malaise, Malignant neoplasm progression, Muscular weakness, Myalgia, Nasopharyngitis, Nausea, Nausea, Pain, Palpitations, Paraesthesia, Pruritus, Recurrent cancer, Seasonal allergy, Skin fissures, Sneezing, Stress, Tumour marker increased, Urinary tract infection, Vulvovaginal pain, Weight decreased, Weight decreased, Weight increased, |
||||
HUMAN IMMUNOGLOBULIN G, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, CAPECITABINE, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, HEPARIN SODIUM AND DEXTROSE, HEPARIN SODIUM, MAGNESIUM, PACLITAXEL, METHYLPREDNISOLONE SODIUM SUCCINATE, TRAMADOL HYDROCHLORIDE, TRASTUZUMAB-QYYP, TRAMADOL HYDROCHLORIDE, |
||||
| 605 | 25035825 |
CA |
9 | 1 |
Joint injury, Fall, Influenza, Skin fissures, Dry skin, Off label use, |
||||
INFLIXIMAB, |
||||
| 606 | 25036550 |
JP |
59 | 2 |
Dermatitis acneiform, Dry skin, Diarrhoea, |
||||
RAMUCIRUMAB, ERLOTINIB HYDROCHLORIDE, ERLOTINIB, |
||||
| 607 | 25036565 |
PL |
73 | 2 |
Thyroid cancer, Metastases to lung, Dry skin, Skin fissures, Oral mucosa erosion, Asthenia, Decreased appetite, Blood triglycerides decreased, |
||||
SORAFENIB, LEVOTHYROXINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLIMEPIRIDE, INDAPAMIDE, LOSARTAN, RAMIPRIL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 608 | 25036978 |
BR |
67 | 1 |
Retinal artery occlusion, Conjunctival haemorrhage, Muscle atrophy, Ankylosing spondylitis, Weight gain poor, Blood cholesterol increased, Hypertension, Dry skin, Therapeutic response shortened, Neck pain, |
||||
INFLIXIMAB, INFLIXIMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 609 | 25038572 |
US |
||
Erythema, Dry skin, Hot flush, |
||||
RELUGOLIX, RELUGOLIX, PREDNISONE, ABIRATERONE ACETATE, ABIRATERONE, |
||||
| 610 | 25038802 |
GB |
44 | 1 |
Dry skin, |
||||
| 611 | 25029431 |
US |
||
Dry skin, Skin exfoliation, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 612 | 25029500 |
US |
4 | 2 |
Dermatitis atopic, Pruritus, Rash erythematous, Dry skin, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 613 | 25029926 |
US |
2 | |
Metastases to central nervous system, Asthenia, Hypokalaemia, Diarrhoea, Herpes zoster, COVID-19, Rash, Palmar-plantar erythrodysaesthesia syndrome, Dry skin, Arthralgia, Myalgia, Skin fissures, Pain in extremity, Intracranial mass, Dermatitis, |
||||
LETROZOLE, LETROZOLE TABLETS, TUCATINIB, TUCATINIB, TUCATINIB, TUCATINIB, CAPECITABINE, CAPECITABINE, CAPECITABINE, TUCATINIB, |
||||
| 614 | 25030318 |
CA |
73 | 1 |
Hospitalisation, Volvulus, Dry skin, |
||||
BRODALUMAB, BRODALUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, HYDROCHLOROTHIAZIDE, ALLOPURINOL, USTEKINUMAB, RAMIPRIL, LIRAGLUTIDE, |
||||
| 615 | 25030866 |
US |
50 | 1 |
Dry skin, Constipation, |
||||
LENALIDOMIDE, |
||||
| 616 | 25031076 |
87 | ||
Skin irritation, Skin disorder, Paraesthesia, Insomnia, Dry skin, Off label use, |
||||
RUXOLITINIB, RUXOLITINIB, ZANUBRUTINIB, ALLOPURINOL, APIXABAN, GABAPENTIN, LOVASTATIN, |
||||
| 617 | 25031801 |
US |
||
Malaise, Therapeutic response shortened, Brain fog, Muscular weakness, Fatigue, Dry skin, |
||||
RISANKIZUMAB-RZAA, |
||||
| 618 | 25031900 |
US |
55 | 1 |
Chronic kidney disease, Dry skin, Pruritus, Product dose omission issue, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
| 619 | 25032426 |
US |
32 | 1 |
Multiple sclerosis relapse, Blindness, Influenza like illness, Fatigue, Chills, Pyrexia, Pain, Injection site pain, Arthritis, Neck pain, Blood testosterone decreased, Dry skin, Blepharospasm, Stress, Feeling hot, Muscle twitching, |
||||
OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, PREDNISONE, |
||||
| 620 | 25032685 |
US |
||
Dry eye, Dry skin, Blister, Onychoclasis, Muscle atrophy, |
||||
RUXOLITINIB, BELUMOSUDIL, |
||||
| 621 | 25033191 |
US |
2 | |
Herpes zoster, Metastases to central nervous system, HER2 positive breast cancer, Malignant neoplasm progression, Hypokalaemia, Diarrhoea, Dermatitis, Arthralgia, Asthenia, Intracranial mass, COVID-19, Drug eruption, Palmar-plantar erythrodysaesthesia syndrome, Myalgia, Pain in extremity, Dry skin, Skin fissures, |
||||
LETROZOLE, LETROZOLE TABLETS, TUCATINIB, TUCATINIB, TUCATINIB, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, ADO-TRASTUZUMAB EMTANSINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, CAPECITABINE, PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, |
||||
| 622 | 25033271 |
CA |
66 | 1 |
Polymyalgia rheumatica, Abdominal pain upper, Increased appetite, Poor quality sleep, Dry skin, Myalgia, |
||||
BRODALUMAB, BRODALUMAB, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, LEVOTHYROXINE SODIUM, LANSOPRAZOLE, HALOBETASOL PROPIONATE AND TAZAROTENE, |
||||
| 623 | 25033438 |
US |
82 | 2 |
Melanocytic naevus, Rash macular, Skin warm, Dermatitis, Acne, Scab, Dry skin, Tension, Nervousness, Pruritus genital, Depression, Fatigue, Asthenia, Malaise, Pain in extremity, Feeling abnormal, Hypersomnia, Disturbance in attention, Restlessness, Pruritus, Pain of skin, Skin exfoliation, Injection site pain, Incorrect dose administered, Product use in unapproved indication, Drug ineffective for unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, AMLODIPINE, LEVOTHYROXINE, HYDROXYZINE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, |
||||
| 624 | 25033451 |
US |
84 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 625 | 25033452 |
US |
2 | |
Dry skin, Lacrimation increased, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 626 | 25033459 |
US |
16 | 1 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 627 | 25033468 |
US |
54 | 2 |
Foot operation, Eczema, Dry skin, Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 628 | 25033471 |
US |
2 | |
Dry skin, Skin exfoliation, Injection site pain, |
||||
DUPILUMAB, FLUOCINOLONE ACETONIDE OIL, FLUOCINOLONE ACETONIDE, ALBUTEROL SULFATE, CRISABOROLE, DESONIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, CETIRIZINE HYDROCHLORIDE, |
||||
| 629 | 25033531 |
US |
24 | 2 |
Rash, Erythema, Dry skin, Skin irritation, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 630 | 25033570 |
US |
2 | |
Pruritus, Dry skin, Limb discomfort, Psychiatric symptom, |
||||
DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BUMETANIDE, GALANTAMINE HYDROBROMIDE, GLIPIZIDE, LETROZOLE, LETROZOLE TABLETS, LEVOTHYROXINE, LISINOPRIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, LIRAGLUTIDE, |
||||
| 631 | 25033639 |
US |
3 | 1 |
Sleep disorder, Dry skin, Pruritus, Skin exfoliation, Skin fissures, Skin haemorrhage, Skin weeping, |
||||
DUPILUMAB, |
||||
| 632 | 25033665 |
US |
2 | |
Dermatitis atopic, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 633 | 25033669 |
US |
27 | 2 |
Rebound eczema, Dry skin, Skin discolouration, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 634 | 25033856 |
US |
69 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 635 | 25033972 |
US |
3 | 1 |
Skin fissures, Dry skin, |
||||
DUPILUMAB, |
||||
| 636 | 25034021 |
US |
57 | 1 |
Dry skin, Rash pruritic, |
||||
DUPILUMAB, |
||||
| 637 | 25036184 |
33 | 2 | |
Injection site pain, Injection site pain, Injection site erythema, Dry skin, Injection site nodule, Swelling, Skin discolouration, |
||||
GALCANEZUMAB-GNLM, LEVOTHYROXINE, AMLODIPINE, HYDROCHLOROTHIAZIDE, LOSARTAN, DIVALPROEX SODIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LAMOTRIGINE, ESCITALOPRAM, |
||||
| 638 | 25041933 |
40 | 2 | |
Nausea, Weight increased, Contusion, Fatigue, Alopecia, Back pain, Vulvovaginal pain, Pruritus, Dry skin, Headache, |
||||
ETONOGESTREL, LISDEXAMFETAMINE DIMESYLATE, ESCITALOPRAM, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, LORAZEPAM, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CALCIUM CARBONATE, SIMETHICONE, SIMETHICONE, CALCIUM CARBONATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 639 | 25028449 |
US |
54 | 2 |
Injection site pain, Dry skin, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 640 | 25028460 |
US |
3 | 2 |
Sleep disorder due to a general medical condition, Dry skin, Skin exfoliation, Skin irritation, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 641 | 25028495 |
US |
1 | 1 |
Dry skin, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 642 | 25028653 |
US |
60 | 2 |
Dry skin, Eye pruritus, Eczema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, AMLODIPINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, LEVOTHYROXINE, MONTELUKAST, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 643 | 25028668 |
US |
46 | 1 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 644 | 25026531 |
CA |
47 | 2 |
Loss of consciousness, Hypoaesthesia, Acne, Drug interaction, Dry skin, Feeling hot, Musculoskeletal stiffness, Formication, Flushing, Loss of consciousness, Rash pruritic, Menopausal symptoms, Menopausal symptoms, Rash pruritic, Formication, Skin burning sensation, Skin burning sensation, Hypoaesthesia, Anxiety, Urticaria, Urticaria, Acne, Musculoskeletal stiffness, Hot flush, Hot flush, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, DULOXETINE HYDROCHLORIDE, GABAPENTIN, DIMETHYL FUMARATE, DIMETHYL FUMARATE, DIMETHYL FUMARATE, DIMETHYL FUMARATE, DIMETHYL FUMARATE, DIMETHYL FUMARATE, |
||||
| 645 | 25026686 |
US |
51 | 2 |
Dry skin, Tooth restoration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 646 | 25026721 |
US |
70 | 2 |
Dry skin, Needle issue, |
||||
DUPILUMAB, |
||||
| 647 | 25026723 |
US |
2 | |
Pruritus, Dry skin, Skin exfoliation, Skin fissures, Skin swelling, Sleep disorder due to a general medical condition, Influenza, Product use in unapproved indication, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GABAPENTIN, HYDRALAZINE HYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OSELTAMIVIR, OSELTAMIVIR PHOSPHATE, PREGABALIN, SPIRONOLACTONE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, |
||||
| 648 | 25026724 |
US |
21 | 1 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 649 | 25026810 |
US |
2 | |
Dry skin, |
||||
DUPILUMAB, |
||||
| 650 | 25026845 |
US |
59 | 2 |
Dry skin, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 651 | 25026867 |
US |
54 | 2 |
Eczema, Skin weeping, Skin fissures, Skin exfoliation, Dry skin, Pruritus, |
||||
DUPILUMAB, ERGOCALCIFEROL, LEVOTHYROXINE SODIUM, |
||||
| 652 | 25026878 |
US |
15 | 2 |
Eczema, Dry skin, |
||||
DUPILUMAB, |
||||
| 653 | 25026893 |
US |
2 | |
Dry skin, |
||||
DUPILUMAB, ISOTRETINOIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, FLUCONAZOLE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PROMETHAZINE, PREDNISONE, |
||||
| 654 | 25026944 |
US |
2 | |
Dry skin, Arthralgia, Product use in unapproved indication, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ROSUVASTATIN, ERGOCALCIFEROL, |
||||
| 655 | 25026951 |
US |
45 | 1 |
Dry skin, Skin fissures, |
||||
DUPILUMAB, DESONIDE, ROSUVASTATIN CALCIUM, |
||||
| 656 | 25026990 |
US |
1 | |
Skin haemorrhage, Skin fissures, Dry skin, Sleep disorder, Skin exfoliation, Pruritus, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CARBAMAZEPINE, EZETIMIBE, METOPROLOL TARTRATE, METOPROLOL, ROSUVASTATIN, |
||||
| 657 | 25027085 |
US |
1 | |
Dermatitis atopic, Dry skin, Rash, |
||||
DUPILUMAB, |
||||
| 658 | 25027097 |
US |
2 | |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 659 | 25027105 |
US |
72 | 1 |
Dry skin, Pruritus, Skin exfoliation, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 660 | 25027108 |
US |
36 | 1 |
Ingrown hair, Eczema, Rash, Dry skin, Skin fissures, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 661 | 25027132 |
US |
28 | 1 |
Dry skin, Pruritus, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 662 | 25027187 |
US |
31 | 1 |
Pruritus, Sleep disorder, Dry skin, Skin exfoliation, Haemorrhage, Skin weeping, Treatment failure, |
||||
DUPILUMAB, |
||||
| 663 | 25027254 |
US |
35 | 1 |
Dry skin, Skin exfoliation, |
||||
DUPILUMAB, ALBUTEROL SULFATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 664 | 25027269 |
US |
46 | 1 |
Haemorrhage, Dry skin, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 665 | 25027289 |
US |
1 | |
Rash, Dry skin, |
||||
DUPILUMAB, |
||||
| 666 | 25027353 |
US |
22 | 1 |
Dry skin, Urticaria, |
||||
DUPILUMAB, PANTOPRAZOLE SODIUM, ESZOPICLONE, |
||||
| 667 | 25027372 |
US |
24 | 1 |
Dry skin, Skin swelling, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 668 | 25027388 |
US |
15 | 2 |
Eczema, Rash macular, Pruritus, Skin haemorrhage, Scratch, Dry skin, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 669 | 25027442 |
US |
3 | 1 |
Skin fissures, Dry skin, Sleep disorder, Pruritus, Therapeutic response shortened, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
| 670 | 25027447 |
US |
54 | 2 |
Hyperkeratosis, Dry skin, Skin tightness, Palmoplantar pustulosis, Condition aggravated, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, IXEKIZUMAB, TIRZEPATIDE, LISINOPRIL, ACITRETIN, |
||||
| 671 | 25027478 |
US |
18 | 2 |
Dry skin, Skin exfoliation, Pruritus, Off label use, |
||||
DUPILUMAB, |
||||
| 672 | 25027490 |
US |
2 | |
Dermatitis atopic, Dry skin, Skin fissures, Pruritus, |
||||
DUPILUMAB, |
||||
| 673 | 25027500 |
US |
21 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Dry skin, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 674 | 25027550 |
US |
22 | 2 |
Rebound atopic dermatitis, Product dose omission issue, Rebound eczema, Erythema, Dry skin, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 675 | 25027605 |
US |
17 | 2 |
Eczema, Dry skin, Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 676 | 25027651 |
US |
48 | 2 |
Dermatitis atopic, Pruritus, Skin exfoliation, Dry skin, Intentional product misuse, |
||||
DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, PROGESTERONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ALPRAZOLAM, SERTRALINE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE, KETOTIFEN FUMARATE, |
||||
| 677 | 25027686 |
US |
1 | |
Rebound atopic dermatitis, Dry skin, |
||||
DUPILUMAB, |
||||
| 678 | 25027690 |
US |
36 | 2 |
Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 679 | 25027692 |
US |
63 | 2 |
Condition aggravated, Dry skin, Peripheral swelling, Pruritus, |
||||
DUPILUMAB, |
||||
| 680 | 25027695 |
US |
14 | 2 |
Dry skin, Injection site pain, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 681 | 25027708 |
US |
66 | 2 |
Dry skin, Skin burning sensation, Pruritus, Asthma, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 682 | 25027712 |
US |
25 | 2 |
Dry skin, Skin fissures, |
||||
DUPILUMAB, |
||||
| 683 | 25027755 |
US |
29 | 2 |
Dry skin, Food allergy, Pruritus, |
||||
DUPILUMAB, |
||||
| 684 | 25027777 |
US |
2 | |
Skin fissures, Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, GABAPENTIN, IBANDRONATE SODIUM, LEVOTHYROXINE, MIRABEGRON, PANTOPRAZOLE, ALBUTEROL SULFATE, |
||||
| 685 | 25027807 |
US |
7 | 1 |
Injection site swelling, Injection site pain, Dry skin, |
||||
DUPILUMAB, |
||||
| 686 | 25027822 |
US |
35 | 2 |
Dry skin, Skin exfoliation, Product administered by wrong person, |
||||
DUPILUMAB, |
||||
| 687 | 25027831 |
US |
36 | 2 |
Rash macular, Dry skin, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 688 | 25027870 |
US |
12 | 2 |
Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, |
||||
| 689 | 25027885 |
US |
26 | 2 |
Alopecia, Eczema, Sensitive skin, Skin burning sensation, Dry skin, Erythema, |
||||
DUPILUMAB, |
||||
| 690 | 25027906 |
US |
35 | 2 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 691 | 25027918 |
US |
48 | 2 |
Eye irritation, Dry eye, Dry skin, |
||||
DUPILUMAB, |
||||
| 692 | 25027959 |
US |
87 | 2 |
Pruritus, Dry skin, Wheezing, |
||||
DUPILUMAB, |
||||
| 693 | 25027967 |
US |
27 | 2 |
Dermatitis atopic, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 694 | 25027984 |
US |
31 | 1 |
Dry skin, Skin fissures, |
||||
DUPILUMAB, |
||||
| 695 | 25028065 |
US |
3 | 2 |
Dry skin, Sleep disorder, Pruritus, |
||||
DUPILUMAB, |
||||
| 696 | 25028103 |
US |
15 | 1 |
Dry skin, Skin exfoliation, Condition aggravated, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 697 | 25028189 |
US |
23 | 2 |
Rash pruritic, Rash erythematous, Abdominal distension, Pruritus, Dry skin, Skin fissures, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 698 | 25028193 |
US |
4 | 2 |
Dry skin, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 699 | 25028199 |
US |
41 | 1 |
Dermatitis atopic, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 700 | 25028201 |
US |
59 | 1 |
Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28